SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes.

By Francis J. Giles, Alison T Stopeck, Lewis R Silverman, J. Lancet, M. Cooper, Alison L. Hannah, J. Cherrington, A. O'Farrell, Helene A. Yuen, S. Louie and 7 more. Blood, 2003

633 citations recorded by the source corpus.

Subfields: Hematology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/8f3388c48627903497e90ba4663907f4798f604f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. Q. Sattentau

Citations in the corpus